Who
G. Doug Iiekking
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, USANA Health Sciences.
In numbers
- Trades disclosed
- 178
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $4.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Jan 2006
- Last trade
- 27 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 28 May 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $101K5,360 at $18.75 | filing |
| 27 May 2026filed 28 May 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Sold | $101K5,360 at $18.75 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —7,469 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $108K5,031 at $21.52 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,469 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,469 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —7,469 | filing |
| 27 Feb 2026filed 3 Mar 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $108K5,031 at $21.52 | filing |
| 19 Feb 2026filed 23 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —41,639 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —41,639 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,084 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —4,084 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $59K2,746 at $21.34 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —4,084 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $59K2,746 at $21.34 | filing |
| 8 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,084 at $0.00 | filing |
| 7 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —2,231 | filing |
| 7 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,231 at $0.00 | filing |
| 7 Feb 2026filed 10 Feb 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $34K1,612 at $21.34 | filing |
| 7 Feb 2026filed 10 Feb 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,231 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.